Mobile Menu
Press Releases

Conyers Receives Top Recognition from China Business Law Journal

China Business Law Journal named Conyers Dill & Pearman as one the “Best law firms for offshore work” in 2015.

The Firm also received three Deal of the Year awards from the publication. Conyers won for their involvement in: 1) China Mobile Games and Entertainment Group’s privatisation, 2) Harmonicare Medical’s Hong Kong IPO and 3) WuXi PharmaTech’s privatisation.

Christopher Bickley, Partner and Head of the Hong Kong office said: “Conyers’ Hong Kong office is at the forefront of corporate finance and capital markets work in the region. These awards signify our strengths and we thank China Business Law Journal for the recognition”.

China Business Law Journal awards firms for their outstanding legal service throughout the year, as nominated by China-focused corporate counsel and legal professionals around the world.

Deals of the Year are detailed below:

China Mobile Games and Entertainment Group’s privatisation
Conyers Dill & Pearman provided Cayman law advice to Orient Hongtai Capital Management (Beijing) Co. Ltd., in connection with its US$700 million acquisition of China Mobile Games and Entertainment Group Limited by way of a “going–private” merger.

Richard Hall of Conyers’ Hong Kong office, advised on the matter, working alongside Wilson Sonsini Goodrich & Rosati and King & Wood Mallesons.

Harmonicare Medical’s Hong Kong IPO
Conyers provided Cayman and BVI legal advice to Harmonicare Medical Holdings Limited, in connection with its HK$1.59 billion IPO on the Main Board of the Hong Kong Stock Exchange.

Harmonicare Medical Holdings Limited is the largest private obstetrics and gynecology specialty hospital group in China and ranked first in terms of group revenue in 2013.

Wynne Lau of Conyers’ Hong Kong office advised on the transaction alongside Shearman & Sterling.

WuXi PharmaTech’s privatisation
Conyers provided Cayman law advice to New WuXi Life Science Ltd. in connection with a US$3.3 billion buyout of WuXi PharmaTech Inc., a US listed Chinese company, which closed in Q4 of 2015.

David Lamb and Angie Chu of Conyers’ Hong Kong office advised on the matter, alongside Wilson Sonsini Goodrich & Rosati, Sullivan & Cromwell, Weil Gotshal & Manges and Fangda Partners.


Christopher W.H. Bickley
Partner, Head of Hong Kong Office

Hong Kong   +852 2842 9556
Mobile  +852 6469 3356

David Lamb

Hong Kong   +852 2842 9511
Mobile  +852 6469 3377

Richard Hall

Hong Kong   +852 2842 9530
Mobile  +852 6469 3355

Angie Chu

Hong Kong   +852 2842 9549
Mobile  +852 6469 3385

Wynne Lau

Hong Kong   +852 2842 9532
Mobile  +852 6113 6070


"I enjoy working with them - they are very dependable, reliable and responsive."
- Chambers Global